Opendata, web and dolomites
H2020 projects about "antibody"
The page lists 161 projects related to the topic "antibody".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | DiViNe | Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes | 2015 |
| 3 | PentaBrain | Structural studies of mammalian Cys-loop receptors | 2015 |
| 4 | PredicTOOL | Nanomethods to understand what makes an endogenous protein immunogenic | 2015 |
| 5 | BLOODCELLSCROSSTALK | The Crosstalk Between Red And White Blood Cells: The Case Of Fish | 2015 |
| 6 | complexNMR | Structural Dynamics of Protein Complexes by Solid-State NMR | 2015 |
| 7 | A CACTUS | Antibody-free method for Counting All Circulating TUmour cellS while maintaining them alive and intact | 2015 |
| 8 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 9 | Immuno-NanoDecoder | Nanostructured molecular decoders for the quantitative, multiplexed, layer-by-layer detection of disease-associated proteins | 2015 |
| 10 | Vaccinesurvey | Monitor population immunity against vaccine preventable diseases | 2015 |
| 11 | MycoTest | Development of fast antibody-based screening tests for the detection of harmful mycotoxins in food and feed | 2015 |
| 12 | ARENAVIRUS | Molecular mechanisms of arenavirus cell entry and antibody-mediated neutralization | 2015 |
| 13 | MSMART | Margination of Microcapsules in Small Arteries | 2015 |
| 14 | PATOX | Development of pyrrolizidine alkaloid detection methods for the assessment of food contamination and impact on human and animal health | 2016 |
| 15 | ImmunoFarm | IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli. | 2015 |
| 16 | NESIAC | Nanobody-enabled Structural Investigation of a G Protein-Coupled Receptor-Arrestin Complex | 2015 |
| 17 | APOBEC | Enzymatic DNA deamination and the immunity/cancer balance | 2015 |
| 18 | RLOOP-AS | Interconnection between R-loops and co-transcriptional alternative splicing | 2015 |
| 19 | MalaDiag | Development of a very rapid diagnostic test for malaria, based on break-through detection technology and new biomarkers of infection. | 2014 |
| 20 | IF-EBOla | Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy | 2014 |
| 21 | BI-MARK | Clinical validation of the CD32b biomarker on the European market | 2015 |
| 22 | TWILIGHT | ToWards Immunisations that Last: the Immunology and Gerontology of Helper T cells | 2015 |
| 23 | NEWCARBOVAX | New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | 2017 |
| 24 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
| 25 | CSC-IS | Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 |
| 26 | IMPAM | Development of a new immunoassay platform based on porous antibody microparticles | 2015 |
| 27 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
| 28 | IMMPACT | Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer. | 2015 |
| 29 | BCELLMECHANICS | Regulation of antibody responses by B cell mechanical activity | 2015 |
| 30 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 31 | ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | 2015 |
| 32 | HisMoDetect | An Antibody Microarray for Histone Modifications | 2015 |
| 33 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 34 | SYSMET | Systems Biology of Membrane Trafficking | 2016 |
| 35 | BROADimmune | Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens | 2015 |
| 36 | NISCI | Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European clinical proof of concept trial | 2016 |
| 37 | PRESCREENARRAY | Peptide arrays as a high throughput pre-screening tool | 2015 |
| 38 | HIV1ABTHERAPY | Antibody-Mediated Therapy of HIV-1 Infection | 2016 |
| 39 | PREG-LAB | Distinctive characterization of regulatory plasma cells and pro-inflammatory B cells in immunity: their origins, molecular properties, and cellular fates. | 2016 |
| 40 | EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 |
| 41 | RITA-MI | Rituximab in Acute Myocardial Infarction | 2016 |
| 42 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 43 | SmartCubes | An innovative class of nanoparticles (“SmartCubes”) for the targeted delivery of protein therapeutics | 2016 |
| 44 | Cells-in-drops | High throughput screening of single-cells using droplet microfluidics | 2016 |
| 45 | BiCyHePepDi | Bicyclic hetero peptidimer - a novel molecule format for therapeutic peptides | 2016 |
| 46 | GutBCells | Cellular Dynamics of Intestinal Antibody-Mediated Immune Response | 2016 |
| 47 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 48 | GCB-PRID | Post-transcriptional Regulation of Germinal Center B Cell Responses in Immunity and Disease | 2016 |
| 49 | Antibodyomics | Vaccine profiling and immunodiagnostic discovery by high-throughput antibody repertoire analysis | 2016 |
| 50 | iGOLDD | Commercialising MR-HIFU: an Image-Guided Local Drug-Delivery Platform | 2016 |
| 51 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
| 52 | AD-VIP | Alzheimer’s disease and AAV9: Use of a virus-based delivery system for vectored immunoprophylaxis in dementia. | 2016 |
| 53 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 54 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 55 | 1toStopVax | RNA virus attenuation by altering mutational robustness | 2016 |
| 56 | HypoSens | Nano-confined photonic system for detection of breast cancer spread to the lymph nodes | 2016 |
| 57 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 58 | CD40-INN | CD40 goes innate: defining and targeting CD40 signaling intermediates in the macrophage to treat atherosclerosis | 2016 |
| 59 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
| 60 | NOTID | Novel treatment of inflammatory diseases | 2016 |
| 61 | NOGOPROOF | Towards clinical trials for a novel treatment for stroke | 2017 |
| 62 | iMDx | Microfiber Electrofluidics for Integrated Molecular Diagnostics | 2017 |
| 63 | GlycoModels | 3D glyco-engineered models to address the role of glycosylation in gastric cancer clinical management | 2017 |
| 64 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
| 65 | GLIOMA | Targeting Glioblastoma using Combinatorial Therapeutic Nanovaccine | 2017 |
| 66 | TNFaLysMyr | Unique TNFα lysine myristoylation; elucidating its function, regulation and integration into inflammation | 2018 |
| 67 | VSV-EBOVAC | Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 | 2015 |
| 68 | IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 |
| 69 | RACE | Rheumatoid Arthritis Caught Early: investigating biological mechanisms preceding chronification of joint inflammation to identify patients prior to presentation of classic chronic arthritis | 2017 |
| 70 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 71 | BCRdangerCOMPETITION | The role of danger signal and cellular competition in the elimination of B cells lacking the B cell receptor. | 2017 |
| 72 | TEMUBLYM | Teleost mucosal B1-like lymphocytes at the crossroad of tolerance and immunity | 2017 |
| 73 | LUMABS | Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone | 2017 |
| 74 | AUTOCOMPLEMENT | The role of complement in the induction of autoimmunity against post-translationally modified proteins | 2017 |
| 75 | PlasmaCellControl | Transcriptional control of plasma cell development and function | 2018 |
| 76 | Tumor-Treg-Targeting | Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours | 2018 |
| 77 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 78 | PRe-ART | Predictive Reagent Antibody Replacement Technology | 2017 |
| 79 | AptaCheck | Bioelectronic lab-on-a-chip for point-of-care detection of infectious agents | 2017 |
| 80 | ARMOR-T | Armoring multifunctional T cells for cancer therapy | 2018 |
| 81 | BioNanoPattern | Protein nano-patterning using DNA nanotechnology; control of surface-based immune system activation | 2018 |
| 82 | SUGARSmart | SUGARSmart: Smart design of recombinant antibody fragments specific for carbohydrate molecules | 2018 |
| 83 | NanoBioMap | Nanoparticle Biointerface Mapping | 2018 |
| 84 | PANBioRA | Personalized And/Or Generalized Integrated Biomaterial Risk Assessment | 2018 |
| 85 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 86 | ImmuneHunter | Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously | 2017 |
| 87 | HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer | 2018 |
| 88 | HIV B Cell Function | Understanding HIV-specific B cell function and viral immunogenicity | 2018 |
| 89 | mABSPN | Antibody-based therapy against Streptococcus pneumoniae | 2018 |
| 90 | ProLiCell | Engineered Protein Nanosheets at Liquid-Liquid Interfaces for Stem Cell Expansion, Sorting and Tissue Engineering | 2018 |
| 91 | ANTILEAK | Development of antagonists of vascular leakage | 2018 |
| 92 | MuSeq | Defining the Oligodendrocyte Lineage in Multiple Sclerosis Lesions by Single Cell RNA-Sequencing | 2018 |
| 93 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 94 | rSAMs-NANO | Nanoparticles with switchable shells for virus sensing and inhibition | 2018 |
| 95 | HTS-STABTHERAPRO | High-throughput directed evolution to engineer thermostable therapeutic proteins | 2018 |
| 96 | PREMOTHER | PREvention of MOther-to-child Transmission of HIV and Syphilis using an Electrochemical Readout based on DNA Switches | 2019 |
| 97 | Multiple Sclerosis | Development of a Functionalised Biomaterial Scaffold to Treat Multiple Sclerosis | 2018 |
| 98 | MRI COMIQSUM | MRI COntrast using MIcrobubbles in Quantitative SUsceptibility Mapping | 2018 |
| 99 | SC-EpiTranscriptome | Investigating differentiation using parallel single cell transcriptomic and epigenomic analysis | 2019 |
| 100 | IN-3D-CAN | Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies | 2018 |
| 101 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
| 102 | MATURE-NK | MAnufacturing of TUmour-REactive Natural Killer cells | 2018 |
| 103 | IMMUNEDIVERSITY | Defining of human adaptive immune gene diversity and its impact on disease | 2018 |
| 104 | Pharma-Factory | Building the product pipeline for commercial demonstration of Plant Molecular Factories | 2017 |
| 105 | EASYFISH | Development of a new biomolecule to better control reproduction in fish | 2018 |
| 106 | AbCURE_COPD | Antibody mediated clearance of senescent cells for treatment of COPD | 2018 |
| 107 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 108 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 109 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 110 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
| 111 | pHioniC | pH and Ion Transport in Pancreatic Cancer | 2018 |
| 112 | DCDP | Digital Cancer Diagnosis Platform | 2018 |
| 113 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 114 | FuncMAB | High-throughput single-cell phenotypic analysis of functional antibody repertoires | 2019 |
| 115 | TopSpec | Next generation precision antibody profiling - from science fiction to reality | 2019 |
| 116 | NIMM | Fluorescence-based nano-immunoassay IVD platform | 2019 |
| 117 | SyntheticPaper | Enabling high performance and cost-efficient Point-of-Care diagnostics using a new innovative synthetic lateral flow substrate | 2019 |
| 118 | TraffikGene | Peptide Dynamic Amphiphiles for Gene Therapy and Macromolecular Delivery | 2019 |
| 119 | IRF4 Degradation | Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells | 2019 |
| 120 | RoBE | Study of the role of BANK1 in antibody production and antibody-independent functions of B cells in SLE | 2019 |
| 121 | APTAFRAME | DNA-origami frame platform for co-evolution ligand selection | 2019 |
| 122 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 123 | COLIBRI | Click chemistry Options for Live Immuno Brain Imaging | 2019 |
| 124 | EpIg Men | The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups | 2019 |
| 125 | NSFTA | New Strategies For Therapeutic Antibodies – Synthetic bispecific antibodies & Antibody-Drug Conjugates with controlled drug loading. General methods for unexplored ADCs and personalised therapies. | 2020 |
| 126 | DNA-NANO-AB | “DNA-based NANOdevices for the point-of-care electrochemical detection of AntiBodies” | 2020 |
| 127 | NanoProt-ID | Proteome profiling using plasmonic nanopore sensors | 2019 |
| 128 | NotToKill-NotToDie | Unrevealing dry season Plasmodium falciparum replication biology | 2019 |
| 129 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 130 | StressOME | Defining and modulating the stress granule proteome as a therapeutic strategy in Amyotrophic Lateral Sclerosis | 2019 |
| 131 | Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa | 2019 |
| 132 | GlycoMabs | Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies | 2019 |
| 133 | iLCA | Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies | 2019 |
| 134 | PATGlycoPrint | Development of a new process analytical technology based on an innovative nanoplasmonic detection array for monitoring glycosylation of monoclonal antibodies | 2019 |
| 135 | NanoPSYCH | Neuropsychiatric disorders are a heterogeneous group of mental pathologies that demand prolonged and treatments that are frequently ineffective. Elucidating the cellular and molecular mechanisms under | 2019 |
| 136 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 137 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 138 | NaviFlu | Navigating the evolutionary routes of influenza viruses | 2019 |
| 139 | TAcTIC | TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer | 2019 |
| 140 | DrugPhosphoProfiler | Accelerating drug and biomarker discovery through a new proteomic service: DrugPhosphoProfiler | 2019 |
| 141 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 142 | OSAvit-D | POINT OF CARE DEVICE FOR VITAMIN D DEFICIENCY MONITORING | 2019 |
| 143 | MABSTER | Monoclonal Antibodies with Binding Sensitive To Environmental Regulation | 2020 |
| 144 | B-DOMINANCE | B Cell Immunodominance in Antiviral Immunity | 2019 |
| 145 | VIVA | Vaccine development against variable pathogens | 2020 |
| 146 | AQUASERS | The European first generation of aquaculture SERS-based Biosensor | 2019 |
| 147 | FIDA | Scale-up of our disruptive antibody analytical platform based in flow-induced dispersion analysis (FIDA) to increase efficiency in the research of new antibodies and vaccines | 2019 |
| 148 | CAESAR | Developing Therapeutic Antibodies for Pets | 2019 |
| 149 | HominAb | Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases | 2019 |
| 150 | MiChomAbs | Synthetic Mini-Chromosomes for Antibody Production | 2019 |
| 151 | B6VitaStat | A diagnostic device for personalized determination of vitamin B6 status and health | 2019 |
| 152 | ACCORDION | Adaptive edge/cloud compute and network continuum over a heterogeneous sparse edge infrastructure to support nextgen applications | 2020 |
| 153 | MInfla-Tilc | Generation of therapeutic antibodies targeting type 2 Innate Lymphoid cells in asthma | 2020 |
| 154 | READY | Getting ready to treat human patients with nanobody-targeted photodynamic therapy | 2020 |
| 155 | MultiSeroSurv | Algorithms and multiplex assays for integrated serological surveillance of malaria and neglected tropical diseases | 2020 |
| 156 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 157 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 158 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 159 | FUSION | Single Molecule Imaging-based design of HIV-1 vaccines | 2020 |
| 160 | ROSETTA | Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer | 2020 |
| 161 | GABARPET | ImmunoPET directed to specific subtypes of GABAA receptors as strategy for molecular mapping of behaviour and mental illness | 2020 |